Login / Signup

Alleviation of Anemia by SGLT2 Inhibitors in Patients with CKD: Mechanisms and Results of Long-Term Placebo-Controlled Trials.

Milton Packer
Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)
Keyphrases
  • chronic kidney disease
  • placebo controlled
  • double blind
  • iron deficiency
  • phase ii
  • phase iii
  • phase ii study
  • squamous cell carcinoma
  • randomized controlled trial
  • open label